V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10480381 | 10054617 | 1.61 | 59.8 | Palliative (P) | 2020-09-11 | 2020-09-16 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100301996 |
| 10480401 | 10054618 | 1.67 | 76.2 | null | 2020-04-13 | 2020-07-14 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 101741382 |
| 10480411 | 10054619 | 1.56 | 80 | null | 2019-08-06 | 2019-08-11 | RUXOLITINIB | null | null | RUXOLITINIB | 101360197 |
| 10480513 | 10054620 | 1.56 | 101.5 | 03 | 2019-12-04 | 2019-12-04 | Avelumab | 02 | N | CARBOPLATIN + GEMCITABINE | 100270357 |
| 10480527 | 10054621 | 1.72 | 48.4 | Adjuvant (A) | 2020-12-01 | 2020-12-09 | Avelumab | 02 | N | VENETOCLAX | 100957815 |
| 10480533 | 10054622 | 1.62 | 88.4 | Palliative (P) | 2022-05-07 | 2022-05-28 | DARATUMUMAB | 02 | null | DARATUMUMAB | 101788375 |
| 10480569 | 10054623 | 1.79 | 58.2 | 03 | 2015-09-06 | 2015-09-06 | Avelumab | 02 | N | AVELUMAB | 101368467 |
| 10480584 | 10054624 | 1.58 | 74.9 | null | 2019-10-23 | 2019-10-25 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100826685 |
| 10480606 | 10054625 | 1.88 | 83.6 | null | 2016-06-04 | 2016-06-25 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 101300159 |
| 10480646 | 10054626 | 1.77 | 86.35 | Curative (C) | 2022-02-18 | 2022-03-10 | Avelumab | 02 | N | DARATUMUMAB | 101402707 |
| 10480656 | 10054627 | 1.7 | null | null | 2019-04-21 | 2019-05-05 | DARATUMUMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 100881397 |
| 10480657 | 10054628 | 1.58 | 71.8 | Disease modification (D) | 2018-07-13 | 2018-07-26 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101607099 |
| 10480685 | 10054629 | 1.68 | 66.8 | 03 | 2017-12-02 | 2017-12-28 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 101028572 |
| 10480728 | 10054631 | 1.66 | 78.8 | null | 2021-05-21 | 2021-06-01 | Bendamustine+Rituximab(Sub Courses) | null | null | BENDAMUSTINE + RITUXIMAB | 101185431 |
| 10480759 | 10054632 | 1.78 | 95.8 | null | 2018-03-20 | 2018-04-09 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 101519673 |
| 10480785 | 10054633 | 1.71 | 58.2 | Palliative (P) | 2018-08-13 | 2018-10-08 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100121183 |
| 10480802 | 10054635 | 1.85 | 74.95 | Palliative (P) | 2019-08-20 | 2019-08-20 | Avelumab | 02 | N | DARATUMUMAB | 100392430 |
| 10480812 | 10054636 | 1.75 | 85 | null | 2020-05-07 | 2020-05-22 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100100274 |
| 10480829 | 10054637 | 1.68 | 75.3 | Neo-adjuvant (N) | null | 2019-08-18 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100092207 |
| 10480832 | 10054638 | 1.72 | 67.4 | 03 | 2020-08-09 | 2020-10-05 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 100544225 |
| 10480863 | 10054639 | 1.72 | 71.85 | null | null | 2016-06-18 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100610907 |
| 10480933 | 10054640 | 1.73 | 103 | null | 2017-11-08 | 2018-08-13 | Avelumab | 02 | null | CEMIPLIMAB | 101083981 |
| 10480951 | 10054641 | 0 | 88.4 | Palliative (P) | 2022-03-30 | 2022-04-04 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101745832 |
| 10480959 | 10054642 | 1.64 | 56.4 | Palliative (P) | 2019-05-11 | 2019-05-23 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100144879 |
| 10480975 | 10054643 | 1.72 | null | Palliative (P) | 2018-01-27 | 2018-01-27 | Avelumab | 02 | N | RUXOLITINIB | 101066240 |
| 10480988 | 10054644 | 1.71 | 89.3 | 03 | 2021-09-20 | 2021-09-21 | Venetoclax | 02 | N | VENETOCLAX | 100625190 |
| 10480995 | 10054645 | 1.84 | 64.7 | null | 2020-04-14 | 2020-11-12 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101534738 |
| 10481044 | 10054646 | 1.71 | 56 | null | 2021-06-29 | 2021-07-13 | Avelumab | 02 | null | AVELUMAB | 101248020 |
| 10481056 | 10054647 | 1.57 | 68.1 | null | 2019-05-09 | 2019-08-01 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100350368 |
| 10481070 | 10054648 | 1.76 | 66.5 | null | 2018-01-30 | 2018-01-30 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101718746 |
| 10481116 | 10054649 | 1.79 | 81 | null | 2019-02-26 | 2019-03-11 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100190087 |
| 10481125 | 10054650 | 1.84 | 84.6 | 03 | 2020-09-01 | 2020-09-24 | Avelumab | 02 | N | VENETOCLAX | 100572122 |
| 10481138 | 10054651 | 1.83 | 54 | Disease modification (D) | 2021-05-02 | 2021-12-01 | Venetoclax | 02 | null | VENETOCLAX | 101394573 |
| 10481148 | 10054652 | 1.78 | 88 | null | 2021-01-24 | 2021-02-08 | NIVOLUMAB | null | null | NIVOLUMAB | 101486603 |
| 10481172 | 10054653 | 1.64 | 97 | Adjuvant (A) | 2022-01-01 | 2022-01-01 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101573458 |
| 10481182 | 10054654 | 1.78 | 85.8 | Palliative (P) | null | 2021-09-25 | Venetoclax | 02 | N | VENETOCLAX | 100901893 |
| 10481225 | 10054655 | 1.56 | 55 | Palliative (P) | 2021-06-18 | 2021-06-27 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101223151 |
| 10481243 | 10054656 | 1.67 | 60.35 | null | 2021-12-05 | 2021-12-18 | NIVOLUMAB | N | null | NIVOLUMAB | 101385240 |
| 10481276 | 10054657 | 0 | 59 | null | 2018-08-28 | 2018-09-22 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101172772 |
| 10481308 | 10054658 | 1.61 | 0 | Palliative (P) | 2019-10-21 | 2019-11-01 | Avelumab | 02 | N | VENETOCLAX | 101289950 |
| 10481333 | 10054659 | 1.57 | 76.6 | null | 2020-09-15 | 2020-09-29 | Venetoclax | 02 | null | VENETOCLAX | 100726379 |
| 10481334 | 10054660 | 1.67 | 50.95 | Palliative (P) | null | 2019-09-14 | Venetoclax | 02 | N | VENETOCLAX | 100792784 |
| 10481520 | 10054662 | 1.77 | 44.5 | Palliative (P) | 2019-02-02 | 2019-02-08 | Avelumab | 02 | N | AVELUMAB | 101227454 |
| 10481547 | 10054663 | 0 | 85.9 | null | 2018-09-29 | 2018-10-18 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100868295 |
| 10481579 | 10054664 | 0 | 54.1 | Adjuvant (A) | 2021-02-02 | 2021-02-03 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100975862 |
| 10481585 | 10054665 | 1.74 | 45.8 | null | 2016-02-26 | 2016-03-03 | CEMIPLIMAB | N | null | CEMIPLIMAB | 101268677 |
| 10481594 | 10054666 | 0 | 86.8 | null | 2021-10-23 | 2021-10-23 | Avelumab | 02 | null | VENETOCLAX | 100636612 |
| 10481663 | 10054667 | 1.72 | 52.1 | Palliative (P) | 2019-06-16 | 2019-09-26 | Avelumab | 02 | N | AVELUMAB | 100960859 |
| 10481676 | 10054668 | 1.68 | 52.1 | null | 2019-08-05 | 2019-09-09 | Venetoclax | 02 | null | VENETOCLAX | 101247159 |
| 10481719 | 10054669 | 1.46 | 86.35 | null | 2015-05-11 | 2016-01-17 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 100027387 |